Pipeline Therapeutics is creating a portfolio of first-in-class small molecules in neuro-regeneration: Synaptogenesis, Remyelination. Founded in 2017, Pipeline Therapeutics is backed by investors that include Versant Ventures, Sectoral Asset Management, Hadean Ventures, Brace Pharma, and RBV Capital and is headquartered in San Diego.